Dapride Trio
Dapagliflozin 10 mg, Sitagliptin 100 mg & Metformin (ER) 500 mg Tablets
A novel approach towards economical management of T2DM & CVD risk
Reduces the risk of cardiovascular death or HHF by 17%
Provide effective glucose lowering & well tolerated in patients with T2DM
Provides synergistic benefits on insulin sensitivity